L. Frölich

Discipline

Psychologie (4)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

Alzheimer's disease (9) Amyloid (8) Biochemical markers (7) âge (6) biomarqueur (6) Proteins (6) Human beings (6) Age (6) Age (6) plasma (6) Apolipoprotein E (5) protéine (4) pathologie (4) information (4) maladie (4) Complement (4) Weights and measures (4) Performance (4) Pathology (4) Dementia (4) Brain (4) Mild cognitive impairment (4) Performance (4) cohorte (4) cerveau (4) maladie (4) test (3) abords (agglomération) (3) Diagnosis (3) Area (3)

Documents écrit par L. Frölich (9) | parle de L. Frölich (0)

Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
L. Kleineidam et al.
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
E. Konijnenberg et al. (27 mai 2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
Inflammatory biomarkers in Alzheimer's disease plasma.
A.R. Morgan et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)